Randomized trial comparing neo‐adjuvant versus adjuvant chemotherapy in operable locally advanced breast cancer (T4b N0‐2 M0)
Authors:
- 24 November 2003
- journal article
- clinical trial
- Published by Wiley in Journal of Surgical Oncology
- Vol. 84 (4) , 192-197
Abstract
Background and Objectives: Locally advanced breast cancer (LABC) remains a major problem in developing countries. While trials utilizing neo‐adjuvant chemotherapy demonstrate superior survival rates compared to historic controls, randomized studies evaluating the precise role of neo‐adjuvant chemotherapy in LABC are lacking. In the present trial, neo‐adjuvant chemotherapy was compared against adjuvant chemotherapy to assess survival advantage in operable T4b N0‐2 M0 breast cancer.Methods: A total of 101 women with operable LABC (T4b N0‐2 M0) were randomized. In arm A, 50 patients received 3 cycles of CEF chemotherapy before and 3 cycles following surgery. In arm B, 51 patients had primary surgery followed by 6 cycles of CEF chemotherapy. In both arms, loco‐regional radiotherapy was given after completion of CEF.Results: The response of primary tumor to neo‐adjuvant chemotherapy was 66%, complete response (CR) 14% and partial response (PR) 52%. Clinical nodal response occurred in 95% of node positive patients. Only two (4%) patients had pathologic CR both in tumor and axilla. There was a significant (P = 0.02) increase in incidence of pathologically negative nodes in arm A. At a median follow up of 25 months, there was no significant difference in overall and disease free survival (DFS) in both arms (P = 0.42 and 0.18). Patients showing a response to neo‐adjuvant chemotherapy had better DFS (P = 0.04) compared to those who had no response.Conclusions: Early results of the study indicate no survival benefit with the inclusion of neo‐adjuvant chemotherapy in LABC (T4b N0‐2 M0). Neo‐adjuvant chemotherapy resulted in significant down staging; good responders had a better DFS compared to those who did not respond. J. Surg. Oncol. 2003;84:192–197.Keywords
This publication has 7 references indexed in Scilit:
- Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.Journal of Clinical Oncology, 1998
- Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18.Journal of Clinical Oncology, 1997
- Feasibility of breast-conservation surgery after induction chemotherapy for locally advanced breast carcinomaCancer, 1992
- Prognostic factors in locally advanced noninflammatory breast cancer. Long-term results following primary chemotherapyBreast Cancer Research and Treatment, 1990
- Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapyCancer, 1988
- Adjuvant chemo- and hormonal therapy in locally advanced breast cancer: a randomized clinical studyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1985
- Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancerCancer Chemotherapy and Pharmacology, 1978